Pfizer allocates 2 billion vaccine doses to poorer countries through COVAX

Pfizer and BionTech will deliver through the international vaccine-sharing facility COVAX some of the 2 billion COVID-19 vaccine doses it announced on Friday as new supplies for low- and middle-income countries.

The doses will be allocated “through bilateral agreements, agreements with supranational organizations as well as our partnership with COVAX,” a Pfizer spokesman said.

Earlier on Friday a BioNTech spokeswoman said: “We are currently still evaluating this.”

1:03 Canada remains ‘committed’ to COVAX vaccine-sharing program, Trudeau says